Senior insider sale
Chief Medical Officer at SYROS PHARMACEUTICALS, INC. — senior position signals high conviction
$16.5K
18.88K shares
What this filing means
ROTH DAVID plans to sell 18.88K shares of SYROS PHARMACEUTICALS, INC. valued at approximately $16.5K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 11/18/2024ACC: 0001972362-24-001674
Officer· Chief Medical Officer
Since Feb 2019
18.88K
Shares to sell
$16.5K
Approx. market value
12.10K
Acquired (3 months)
1
Planned
1 completed
Securities Acquired — Last 3 Months1
RESTRICTED STOCK
COMPENSATION
10/31/2024
12.10KTotal acquired12.10K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
10/31/2024 | RESTRICTED STOCK COMPENSATION | 12.10K | — |
| Total | 12.10K | ||
Planned & Completed Dispositions2
Completed
—Completed
Units to sell
6.78K
Market value
$14.2K
11/1/2024
Planned — Approximate Date
NASDAQPlanned
Units to sell
12.10K
Market value
$2.4K
11/18/2024
Total
Units
18.88K
Value
$16.5K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
11/1/2024 | 6.78K | $14.2K | — | Completed |
| Planned — Approximate Date | ||||
11/18/2024 | 12.10K | $2.4K | NASDAQ | Planned |
| Total | 18.88K | $16.5K | ||